 | • レポートコード：MRC2-11QY01676 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はA型インフルエンザウイルス・H3N2亜型感染症薬のグローバル市場について調査・分析したレポートです。種類別（NEO-8877、NP-025、NSC-61610、NVINF-1、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別A型インフルエンザウイルス・H3N2亜型感染症薬の競争状況、市場シェア ・世界のA型インフルエンザウイルス・H3N2亜型感染症薬市場：種類別市場規模 2015年-2020年（NEO-8877、NP-025、NSC-61610、NVINF-1、その他） ・世界のA型インフルエンザウイルス・H3N2亜型感染症薬市場：種類別市場規模予測 2021年-2026年（NEO-8877、NP-025、NSC-61610、NVINF-1、その他） ・世界のA型インフルエンザウイルス・H3N2亜型感染症薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のA型インフルエンザウイルス・H3N2亜型感染症薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のA型インフルエンザウイルス・H3N2亜型感染症薬市場分析：米国、カナダ ・ヨーロッパのA型インフルエンザウイルス・H3N2亜型感染症薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのA型インフルエンザウイルス・H3N2亜型感染症薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のA型インフルエンザウイルス・H3N2亜型感染症薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのA型インフルエンザウイルス・H3N2亜型感染症薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc、AIMM Therapeutics B.V.、Aphios Corporation、Celltrion, Inc.、FluGen, Inc.、Glide Pharmaceutical Technologies Limited、ILiAD Biotechnologies, LLC、Inovio Pharmaceuticals, Inc.、Johnson & Johnson、Medicago Inc.、MedImmune, LLC、Mucosis B.V.、NanoViricides, Inc.、OPKO Health, Inc.、Sarepta Therapeutics, Inc.、VBI Vaccines Inc.、Visterra, Inc.、Zydus Cadila Healthcare Limited ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Influenza A Virus, H3N2 Subtype Infections Drug Market
The global Influenza A Virus, H3N2 Subtype Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Influenza A Virus, H3N2 Subtype Infections Drug Scope and Market Size
Influenza A Virus, H3N2 Subtype Infections Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza A Virus, H3N2 Subtype Infections Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Influenza A Virus, H3N2 Subtype Infections Drug market is segmented into
NEO-8877
NP-025
NSC-61610
NVINF-1
Others
Segment by Application, the Influenza A Virus, H3N2 Subtype Infections Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Influenza A Virus, H3N2 Subtype Infections Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza A Virus, H3N2 Subtype Infections Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza A Virus, H3N2 Subtype Infections Drug Market Share Analysis
Influenza A Virus, H3N2 Subtype Infections Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza A Virus, H3N2 Subtype Infections Drug business, the date to enter into the Influenza A Virus, H3N2 Subtype Infections Drug market, Influenza A Virus, H3N2 Subtype Infections Drug product introduction, recent developments, etc.
The major vendors covered:
AbbVie Inc
AIMM Therapeutics B.V.
Aphios Corporation
Celltrion, Inc.
FluGen, Inc.
Glide Pharmaceutical Technologies Limited
ILiAD Biotechnologies, LLC
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Medicago Inc.
MedImmune, LLC
Mucosis B.V.
NanoViricides, Inc.
OPKO Health, Inc.
Sarepta Therapeutics, Inc.
VBI Vaccines Inc.
Visterra, Inc.
Zydus Cadila Healthcare Limited
1 Study Coverage
1.1 Influenza A Virus, H3N2 Subtype Infections Drug Product Introduction
1.2 Market Segments
1.3 Key Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Type
1.4.2 NEO-8877
1.4.3 NP-025
1.4.4 NSC-61610
1.4.5 NVINF-1
1.4.6 Others
1.5 Market by Application
1.5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size, Estimates and Forecasts
2.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue 2015-2026
2.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales 2015-2026
2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza A Virus, H3N2 Subtype Infections Drug Competitor Landscape by Players
3.1 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers
3.1.1 Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers (2015-2020)
3.1.2 Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers
3.2.1 Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers (2015-2020)
3.2.2 Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza A Virus, H3N2 Subtype Infections Drug Revenue in 2019
3.2.5 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Manufacturers
3.4 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturing Base Distribution, Product Types
3.4.1 Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Product Type
3.4.3 Date of International Manufacturers Enter into Influenza A Virus, H3N2 Subtype Infections Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Type (2015-2020)
4.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020)
4.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type (2015-2020)
4.1.3 Influenza A Virus, H3N2 Subtype Infections Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Type (2021-2026)
4.2.3 Influenza A Virus, H3N2 Subtype Infections Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Application (2015-2020)
5.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020)
5.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Application (2015-2020)
5.1.3 Influenza A Virus, H3N2 Subtype Infections Drug Price by Application (2015-2020)
5.2 Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza A Virus, H3N2 Subtype Infections Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Influenza A Virus, H3N2 Subtype Infections Drug by Country
6.1.1 North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
6.1.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
6.3 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug by Country
7.1.1 Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
7.1.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
7.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug by Region
8.1.1 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region
8.1.2 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
8.3 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Influenza A Virus, H3N2 Subtype Infections Drug by Country
9.1.1 Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
9.1.2 Latin America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
9.3 Central & South America Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug by Country
10.1.1 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country
10.1.2 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Type
10.3 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.1.5 AbbVie Inc Related Developments
11.2 AIMM Therapeutics B.V.
11.2.1 AIMM Therapeutics B.V. Corporation Information
11.2.2 AIMM Therapeutics B.V. Description and Business Overview
11.2.3 AIMM Therapeutics B.V. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.2.5 AIMM Therapeutics B.V. Related Developments
11.3 Aphios Corporation
11.3.1 Aphios Corporation Corporation Information
11.3.2 Aphios Corporation Description and Business Overview
11.3.3 Aphios Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.3.5 Aphios Corporation Related Developments
11.4 Celltrion, Inc.
11.4.1 Celltrion, Inc. Corporation Information
11.4.2 Celltrion, Inc. Description and Business Overview
11.4.3 Celltrion, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.4.5 Celltrion, Inc. Related Developments
11.5 FluGen, Inc.
11.5.1 FluGen, Inc. Corporation Information
11.5.2 FluGen, Inc. Description and Business Overview
11.5.3 FluGen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.5.5 FluGen, Inc. Related Developments
11.6 Glide Pharmaceutical Technologies Limited
11.6.1 Glide Pharmaceutical Technologies Limited Corporation Information
11.6.2 Glide Pharmaceutical Technologies Limited Description and Business Overview
11.6.3 Glide Pharmaceutical Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.6.5 Glide Pharmaceutical Technologies Limited Related Developments
11.7 ILiAD Biotechnologies, LLC
11.7.1 ILiAD Biotechnologies, LLC Corporation Information
11.7.2 ILiAD Biotechnologies, LLC Description and Business Overview
11.7.3 ILiAD Biotechnologies, LLC Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.7.5 ILiAD Biotechnologies, LLC Related Developments
11.8 Inovio Pharmaceuticals, Inc.
11.8.1 Inovio Pharmaceuticals, Inc. Corporation Information
11.8.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
11.8.3 Inovio Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.8.5 Inovio Pharmaceuticals, Inc. Related Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Description and Business Overview
11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.9.5 Johnson & Johnson Related Developments
11.10 Medicago Inc.
11.10.1 Medicago Inc. Corporation Information
11.10.2 Medicago Inc. Description and Business Overview
11.10.3 Medicago Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.10.5 Medicago Inc. Related Developments
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Products Offered
11.1.5 AbbVie Inc Related Developments
11.12 Mucosis B.V.
11.12.1 Mucosis B.V. Corporation Information
11.12.2 Mucosis B.V. Description and Business Overview
11.12.3 Mucosis B.V. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Mucosis B.V. Products Offered
11.12.5 Mucosis B.V. Related Developments
11.13 NanoViricides, Inc.
11.13.1 NanoViricides, Inc. Corporation Information
11.13.2 NanoViricides, Inc. Description and Business Overview
11.13.3 NanoViricides, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 NanoViricides, Inc. Products Offered
11.13.5 NanoViricides, Inc. Related Developments
11.14 OPKO Health, Inc.
11.14.1 OPKO Health, Inc. Corporation Information
11.14.2 OPKO Health, Inc. Description and Business Overview
11.14.3 OPKO Health, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.14.4 OPKO Health, Inc. Products Offered
11.14.5 OPKO Health, Inc. Related Developments
11.15 Sarepta Therapeutics, Inc.
11.15.1 Sarepta Therapeutics, Inc. Corporation Information
11.15.2 Sarepta Therapeutics, Inc. Description and Business Overview
11.15.3 Sarepta Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sarepta Therapeutics, Inc. Products Offered
11.15.5 Sarepta Therapeutics, Inc. Related Developments
11.16 VBI Vaccines Inc.
11.16.1 VBI Vaccines Inc. Corporation Information
11.16.2 VBI Vaccines Inc. Description and Business Overview
11.16.3 VBI Vaccines Inc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 VBI Vaccines Inc. Products Offered
11.16.5 VBI Vaccines Inc. Related Developments
11.17 Visterra, Inc.
11.17.1 Visterra, Inc. Corporation Information
11.17.2 Visterra, Inc. Description and Business Overview
11.17.3 Visterra, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Visterra, Inc. Products Offered
11.17.5 Visterra, Inc. Related Developments
11.18 Zydus Cadila Healthcare Limited
11.18.1 Zydus Cadila Healthcare Limited Corporation Information
11.18.2 Zydus Cadila Healthcare Limited Description and Business Overview
11.18.3 Zydus Cadila Healthcare Limited Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Zydus Cadila Healthcare Limited Products Offered
11.18.5 Zydus Cadila Healthcare Limited Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza A Virus, H3N2 Subtype Infections Drug Market Estimates and Projections by Region
12.1.1 Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Regions 2021-2026
12.2 North America Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
12.2.1 North America: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
12.2.2 North America: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
12.2.3 North America: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
12.3.2 Europe: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Influenza A Virus, H3N2 Subtype Infections Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza A Virus, H3N2 Subtype Infections Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Influenza A Virus, H3N2 Subtype Infections Drug Market Segments
Table 2. Ranking of Global Top Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of NEO-8877
Table 5. Major Manufacturers of NP-025
Table 6. Major Manufacturers of NSC-61610
Table 7. Major Manufacturers of NVINF-1
Table 8. Major Manufacturers of Others
Table 9. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Influenza A Virus, H3N2 Subtype Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza A Virus, H3N2 Subtype Infections Drug as of 2019)
Table 18. Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Price (2015-2020) (USD/Pcs)
Table 21. Influenza A Virus, H3N2 Subtype Infections Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza A Virus, H3N2 Subtype Infections Drug Product Type
Table 23. Date of International Manufacturers Enter into Influenza A Virus, H3N2 Subtype Infections Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Share by Type (2015-2020)
Table 27. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Share by Type (2015-2020)
Table 29. Influenza A Virus, H3N2 Subtype Infections Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Share by Application (2015-2020)
Table 32. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2015-2020)
Table 34. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2015-2020)
Table 38. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2015-2020)
Table 72. AbbVie Inc Corporation Information
Table 73. AbbVie Inc Description and Major Businesses
Table 74. AbbVie Inc Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AbbVie Inc Product
Table 76. AbbVie Inc Recent Development
Table 77. AIMM Therapeutics B.V. Corporation Information
Table 78. AIMM Therapeutics B.V. Description and Major Businesses
Table 79. AIMM Therapeutics B.V. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AIMM Therapeutics B.V. Product
Table 81. AIMM Therapeutics B.V. Recent Development
Table 82. Aphios Corporation Corporation Information
Table 83. Aphios Corporation Description and Major Businesses
Table 84. Aphios Corporation Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Aphios Corporation Product
Table 86. Aphios Corporation Recent Development
Table 87. Celltrion, Inc. Corporation Information
Table 88. Celltrion, Inc. Description and Major Businesses
Table 89. Celltrion, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Celltrion, Inc. Product
Table 91. Celltrion, Inc. Recent Development
Table 92. FluGen, Inc. Corporation Information
Table 93. FluGen, Inc. Description and Major Businesses
Table 94. FluGen, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. FluGen, Inc. Product
Table 96. FluGen, Inc. Recent Development
Table 97. Glide Pharmaceutical Technologies Limited Corporation Information
Table 98. Glide Pharmaceutical Technologies Limited Description and Major Businesses
Table 99. Glide Pharmaceutical Technologies Limited Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Glide Pharmaceutical Technologies Limited Product
Table 101. Glide Pharmaceutical Technologies Limited Recent Development
Table 102. ILiAD Biotechnologies, LLC Corporation Information
Table 103. ILiAD Biotechnologies, LLC Description and Major Businesses
Table 104. ILiAD Biotechnologies, LLC Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. ILiAD Biotechnologies, LLC Product
Table 106. ILiAD Biotechnologies, LLC Recent Development
Table 107. Inovio Pharmaceuticals, Inc. Corporation Information
Table 108. Inovio Pharmaceuticals, Inc. Description and Major Businesses
Table 109. Inovio Pharmaceuticals, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Inovio Pharmaceuticals, Inc. Product
Table 111. Inovio Pharmaceuticals, Inc. Recent Development
Table 112. Johnson & Johnson Corporation Information
Table 113. Johnson & Johnson Description and Major Businesses
Table 114. Johnson & Johnson Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Johnson & Johnson Product
Table 116. Johnson & Johnson Recent Development
Table 117. Medicago Inc. Corporation Information
Table 118. Medicago Inc. Description and Major Businesses
Table 119. Medicago Inc. Influenza A Virus, H3N2 Subtype Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Medicago Inc. Product
Table 121. Medicago Inc. Recent Development
Table 122. MedImmune, LLC Corporation Information
Table 123. MedImmune, LLC Description and Major Businesses
Table 124. MedImmune, LLC Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. MedImmune, LLC Product
Table 126. MedImmune, LLC Recent Development
Table 127. Mucosis B.V. Corporation Information
Table 128. Mucosis B.V. Description and Major Businesses
Table 129. Mucosis B.V. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Mucosis B.V. Product
Table 131. Mucosis B.V. Recent Development
Table 132. NanoViricides, Inc. Corporation Information
Table 133. NanoViricides, Inc. Description and Major Businesses
Table 134. NanoViricides, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. NanoViricides, Inc. Product
Table 136. NanoViricides, Inc. Recent Development
Table 137. OPKO Health, Inc. Corporation Information
Table 138. OPKO Health, Inc. Description and Major Businesses
Table 139. OPKO Health, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. OPKO Health, Inc. Product
Table 141. OPKO Health, Inc. Recent Development
Table 142. Sarepta Therapeutics, Inc. Corporation Information
Table 143. Sarepta Therapeutics, Inc. Description and Major Businesses
Table 144. Sarepta Therapeutics, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Sarepta Therapeutics, Inc. Product
Table 146. Sarepta Therapeutics, Inc. Recent Development
Table 147. VBI Vaccines Inc. Corporation Information
Table 148. VBI Vaccines Inc. Description and Major Businesses
Table 149. VBI Vaccines Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. VBI Vaccines Inc. Product
Table 151. VBI Vaccines Inc. Recent Development
Table 152. Visterra, Inc. Corporation Information
Table 153. Visterra, Inc. Description and Major Businesses
Table 154. Visterra, Inc. Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. Visterra, Inc. Product
Table 156. Visterra, Inc. Recent Development
Table 157. Zydus Cadila Healthcare Limited Corporation Information
Table 158. Zydus Cadila Healthcare Limited Description and Major Businesses
Table 159. Zydus Cadila Healthcare Limited Influenza A Virus, H3N2 Subtype Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 160. Zydus Cadila Healthcare Limited Product
Table 161. Zydus Cadila Healthcare Limited Recent Development
Table 162. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 163. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share Forecast by Regions (2021-2026)
Table 164. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 165. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 166. North America: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 167. North America: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Europe: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 169. Europe: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 171. Asia Pacific: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 172. Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 173. Latin America: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 174. Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 175. Middle East and Africa: Influenza A Virus, H3N2 Subtype Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 177. Key Challenges
Table 178. Market Risks
Table 179. Main Points Interviewed from Key Influenza A Virus, H3N2 Subtype Infections Drug Players
Table 180. Influenza A Virus, H3N2 Subtype Infections Drug Customers List
Table 181. Influenza A Virus, H3N2 Subtype Infections Drug Distributors List
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza A Virus, H3N2 Subtype Infections Drug Product Picture
Figure 2. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type in 2020 & 2026
Figure 3. NEO-8877 Product Picture
Figure 4. NP-025 Product Picture
Figure 5. NSC-61610 Product Picture
Figure 6. NVINF-1 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Influenza A Virus, H3N2 Subtype Infections Drug Report Years Considered
Figure 13. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region in 2019
Figure 18. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Region in 2019
Figure 20. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Influenza A Virus, H3N2 Subtype Infections Drug Revenue in 2019
Figure 22. Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Type in 2019
Figure 25. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Type in 2019
Figure 27. Global Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Price Range (2015-2020)
Figure 28. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Application in 2019
Figure 30. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Application in 2019
Figure 32. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country in 2019
Figure 35. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Type in 2019
Figure 41. North America Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application in 2019
Figure 42. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country in 2019
Figure 45. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country in 2019
Figure 46. Germany Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Type in 2019
Figure 57. Europe Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application in 2019
Figure 58. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Region in 2019
Figure 62. China Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Type in 2019
Figure 85. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application in 2019
Figure 86. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country in 2019
Figure 89. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Type in 2019
Figure 97. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Market Share by Application in 2019
Figure 110. North America Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Influenza A Virus, H3N2 Subtype Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
エプスタインバーウイルス（HHV-4）感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Epstein-Barr Virus (HHV-4) Infections Treatment Market The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Epstein-Barr Virus …- ジカウイルス感染症治療薬の世界市場（～2026年） It is used to treat various uncomfortable symptoms caused by zika virus infection. Market Analysis and Insights: Global Zika Virus Infection Drug Market The global Zika Virus Infection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during…
- 類鼻疽菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Burkholderia Pseudomallei Infections Drug Market The global Burkholderia Pseudomallei Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Burkholderia Pseudomallei Infec…
- ライノウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rhinovirus Infections Drug Market The global Rhinovirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rhinovirus Infections Drug Scope and Market Size Rhinovirus I…
- ロタウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rotavirus Infections Drug Market The global Rotavirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rotavirus Infections Drug Scope and Market Size Rotavirus Infec…